Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...